期刊文献+

兰索拉唑和阿莫西林配合伊托必利治疗功能性消化不良疗效观察 被引量:4

Clinical Efficacy Observation of Functional Dyspepsia Patients with Lansoprazole and Amoxicillin Combined Itopride
暂未订购
导出
摘要 目的兰索拉唑和阿莫西林配合伊托必利治疗功能性消化不良疗效观察。方法将106例功能性消化不良患者,随机分成治疗组和对照组,每组各53例,治疗组口服兰索拉唑30mg/次,1次/d,每早空腹服;阿莫西林1000mg/次,3次/d,早中晚餐后服用;依托必利50mg/次,3次/d,早中晚餐后服用;疗程4周。对照组口服依托必利用法用量和疗程与治疗组相同。结果治愈率和总有效率治疗组在治疗功能性消化不良上均优于对照组。两组药物不良反应发生率无显著差异。结论治疗组在治疗功能性消化不良上均优于对照组,不良反应发生率无显著差异,值得临床推广。 Objective To discuss the clinical efficacy observation of functional dyspepsia with lansoprazole and arnoxicillin combined itopride. Methods 106 patients with functional dyspepsia were randomly divided into treatment group and control group, 53 cases in each group, treatment group was treated with lansoprazole 30mg per times, 1 time per day, every morning fasting suits; amoxicillin 1000mg per time, 3 times per day, after taking early lunch and dinner; Itopride 50mg per times, 3 times per day, after taking early lunch and dinner; treatment for 4 weeks. The control group will rely on the use of oral dosage and the treatment method and treatment of the same set. Results The cure rate and total effective treatment group in the Ireatment of functional dyspepsia is superior to the control group. The two groups the incidence of adverse drug reactions was no significant difference. Conclusions Treatment group in the treatment of functional dyspepsia is superior to the control group, the incidence of adverse reactions was no significant difference, worthy to be popularized.
作者 刘华东
出处 《中国医药指南》 2010年第6期29-30,共2页 Guide of China Medicine
关键词 功能性消化不良 伊托必利 兰索拉唑 阿莫西林 Functional dyspepsia Itopride Lansoprazole Amoxicillin
  • 相关文献

参考文献8

  • 1陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 2Talley NJ,Stanghellini V, Heading RC,et al. Functional gastrodu- odenal disorde[J]. Gut, 1999,45 (Suppl 2):37-42.
  • 3Quartero AO,De Wit NJ,Lodder AC,et al. Disturbed solid-phase gastric emptying in functional dyspepsia : a meta analysis[J]. Dig Dis Sci,1998,43(9):2028-2033.
  • 4Mertz H,Fullerton S,Naliboff B,et al. Symptoms and visceral perception and severe function and organic dyspepsia[J]. Gut,1998, 42(6):814-822.
  • 5上海多潘立酮多中心临床研究协作组.多潘立酮片治疗功能性消化不良的临床研究[J].中华消化杂志,2003,23(4):220-222. 被引量:110
  • 6侯晓华.开展对功能性消化不良的病理生理研究[J].中华消化杂志,2003,23(2):69-70. 被引量:195
  • 7赵瑞祥.伊托必利的药理与临床应用[J].中国疗养医学,2005,14(1):17-18. 被引量:4
  • 8张生声,王垂杰,沈洪.消化病特色专科实用手册[M].北京:中国中医药出版社,2008:70-76.

二级参考文献8

  • 1Dominguez-Munoz JE. Targeting the abnormalities of gastroduodenal functions in funetional dyspepsia[J]. Dig Dis,2001,19(3) :195-200.
  • 2Iwanaga Y, Miyashita N, SaitoT, et al. Gastroprokinetic effect of anew benzamide derivative itopride and its action mechanisms in conscious dogs[J]. Jpn JPh J Phrmacol,1996,71(2) :129-137.
  • 3Mushiroda T, Douya R,Takahara E, et al. The involvement of flavin-containing monooxgenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent:comparison with cisapride and mosapride citrate[J]. Drug Metab Dispos,2000,28(10) : 1231-1237.
  • 4Miyoshi A, Omata S, MiwaT, et al. Clinical effect of HSR-803 on digestive symptoms: early phase Ⅱ study[J].Jpn Pharmacol Ther,1993,11(21):4175-4187.
  • 5Miyoshi A, Masamune O, Sekiguchi T, et al. Clinical evaluation of itopride hydrochloride for gastrointestinal symptoms associated with chronic gastritis: multi-center double-blind clinical trial using cisapride as control drug[J]. Jpn Pharmacol Ther, 1994,12(4) :261 -279.
  • 6侯晓华.非溃疡性消化不良[A].见:侯晓华主编.消化道运动学[C].北京:科学出版社,1998.271~290.
  • 7邹多武,许国铭.功能性消化不良症状流行病学及西沙必利治疗多因素分析[J].引进国外医药技术与设备,1999,5(2):23-25. 被引量:12
  • 8林金坤,胡品津,李初俊,邓会芬,陈为.功能性消化不良胃电图与胃窦部动力[J].中华消化杂志,2002,22(5):315-316. 被引量:94

共引文献1970

同被引文献11

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部